According to MingMed Biotechnology, 1 the QA102-CS201 trial enrolled 150 patients with intermediate atrophic AMD and randomly ...
The Norman Public Schools Board of Education approved the purchase of land for a new farm, heard proposed changes to a board ...
MingMed Biotechnology Co., Ltd, a biomedical firm focused on the discovery and development of novel therapeutics across multiple therapeutic areas, announced positive results from its Phase II ...
MingMed Biotechnology Co., Ltd, a biomedical firm focused on the discovery and development of novel therapeutics across multiple therapeutic areas ...
Good morning, and welcome to Ocugen First Quarter 2026 Financial Results and Business Update. [Operator Instructions] I will now turn the call over to Tiffany Hamilton, Ocugen's Head of Corporate ...
Discusses BGE-102 Clinical Results and Development Strategy for Cardiovascular and Retinal Disease May 8, 2026 12:30 PM ...
Background The standard of care for neovascular age-related macular degeneration (nAMD) is repeated intravitreal injection ...
A new federally funded research effort in Rochester is aiming to tackle one of the biggest gaps in treating age-related macular degeneration — stopping vision loss before it starts. Researchers at ...
High blood pressure and high cholesterol can increase the risk of age-related macular degeneration (AMD) progressing to geographic atrophy (GA), an advanced form that causes permanent vision loss.
Mark Gurarie is a writer covering health topics, technology, music, books, and culture. He also teaches health science and research writing at George Washington University's School of Medical and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results